HS 3003-31-00-00 – Containing insulin
Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026
Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale. › Containing insulin › Containing insulin
- MFN duty rate
- Free
- GST
- 5%
- Unit of measure
- KGM
Containing insulin
Estimate duty & taxes · Get classification help
Preferential tariff rates
- Commonwealth Caribbean Countries Tariff (CCCT): Free
- Ukraine: Free
- CPTPP – United Kingdom (CPUKT): Free
- Colombia: Free
- CPTPP: Free
- Iceland: Free
- Honduras (HNT): Free
- Israel (CIAT): Free
- Costa Rica (CRT): Free
- Panama (PAT): Free
- MXT/CUSMA (Mexico): Free
- UST/CUSMA (US): Free
- Peru: Free
- CETA: Free
- GPT: Free
- Switzerland–Liechtenstein (SLT): Free
- Chile: Free
- Korea: Free
- UK: Free
- Norway (NT): Free
- Jordan (JT): Free
- LDCT: Free
Preference requires qualifying origin and origin proof or certification.
Frequently asked questions
What is the MFN duty on Containing insulin (HS 3003-31-00-00)?
The T2026-2 MFN rate for tariff item 3003.31.00 is Free. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.
What is the duty on HS 3003-31-00-00 from the US?
Qualifying US-origin goods with origin proof use UST/CUSMA at Free. This item is not on any US surtax schedule in force in TariffPlus surtax data (checked against CBSA). GST/HST and any applicable personal-import provincial tax are additional.
Which trade agreement rates apply to HS 3003-31-00-00?
Commonwealth Caribbean Countries Tariff (CCCT): Free; Ukraine: Free; CPTPP – United Kingdom (CPUKT): Free; Colombia: Free; CPTPP: Free; Iceland: Free; Honduras (HNT): Free; Israel (CIAT): Free; Costa Rica (CRT): Free; Panama (PAT): Free; MXT/CUSMA (Mexico): Free; UST/CUSMA (US): Free; Peru: Free; CETA: Free; GPT: Free; Switzerland–Liechtenstein (SLT): Free; Chile: Free; Korea: Free; UK: Free; Norway (NT): Free; Jordan (JT): Free; LDCT: Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.